Ameriabank concluded loan agreement with Swiss SYMBIOTICS SA for $ 11.5 million on development of SMEs in Armenia

ArmInfo. Ameriabank announces, that it has signed a USD 11.5 million senior loan agreement with Symbiotics' Micro, Small & Medium Enterprises Bond issuance program, with a possibility to increase the amount by an additional USD 10 million in hard or local currency.  The loan facility is aimed at financing micro, small or medium enterprise clients of Ameriabank.

Artak Hanesyan, CEO of Ameriabank, commented "We are pleased to announce about a new loan facility aimed at micro and SME financing, which is a strategic priority for Ameriabank.  This is our first transaction with a new valuable partner - Symbiotics, and we look forward to our long-term fruitful cooperation".

Daniel Schriber, Director of Investments at Symbiotics noted: "We are delighted to establish a new partnership with such a reputable and innovative bank as Ameriabank and look forward to our valued cooperation in championing the development and growth of micro-, small- and medium-sized enterprises in Armenia."

Ameriabank is a dynamically developing bank and one of the major and most stable financial institutions in Armenia. The first investment bank in Armenia, Ameriabank has been providing a large package of innovative banking services since 2007. Now Ameriabank CJSC is a universal bank offering corporate, investment and retail banking services in a comprehensive package of banking solutions. For further information, please visit www.ameriabank.am.

Symbiotics, incorporated in 2004 in Geneva, is an investment company specialized in emerging, sustainable and inclusive finance which offers market research, investment advisory and asset management services. It is an asset manager of collective investment schemes regulated by FINMA, the Swiss Financial Market Supervisory Authority and has an advisory license from the FCA, the Financial Conduct Authority, through its subsidiary in the UK. The company, headquartered in Geneva, with offices in London, Amsterdam, Zurich, Cape Town, Mexico City and Singapore, has a staff of over 130 professionals. Since inception, Symbiotics has invested over USD 4 billion in more than 375 microfinance institutions in 68 emerging countries, working with 44 investment funds and many institutional investors.